Aimmune Therapeutics
Why Robinhood?
You can watch AIMT and buy or sell other stocks, ETFs, and their options commission-free!About AIMT
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system.
AIMT Key Statistics
Stock Snapshot
With a market cap of 2.26B, Aimmune Therapeutics(AIMT) trades at $34.49. The stock has a price-to-earnings ratio of -7.68.
During the trading day, Aimmune Therapeutics(AIMT) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Aimmune Therapeutics(AIMT) stock has reached 0, versus its average volume of 1.45M.
Over the past 52 weeks, Aimmune Therapeutics(AIMT) stock has traded between a high of $37.00 and a low of $10.09.
Over the past 52 weeks, Aimmune Therapeutics(AIMT) stock has traded between a high of $37.00 and a low of $10.09.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.